LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
RCKY
Rocky Brands, Inc.
RCKY has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
RCKY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
RCKY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
RCKY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $46.61 | -9.9% |
| Current | 11x | $51.71 | — |
| Fair | 13x | $58.73 | +14% |
| Forward | 13x | $51.71 | — |
| Expensive | 17x | $75.66 | +46% |
Historical ranges are pointers, not guarantees.
RCKY's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 13x, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
RCKY Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RCKY, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
RCKY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | -10% |
| Q3 2026 | $4.55 | +65% |
| Q2 2026 | $3.82 | +53% |
| Q1 2026 | $2.47 | +34% |
| Q4 2025 | $2.96 | +95% |
| Q3 2025 | $2.75 | +55% |
| Q2 2025 | $2.49 | +25% |
| Q1 2025 | $1.84 | +2.2% |
| Q4 2024 | $1.52 | +7.8% |
RCKY has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over RCKY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
RCKY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $138.8M | +13% |
| Q2 2026 | $118.4M | +12% |
| Q1 2026 | $124.4M | +9.1% |
| Q4 2025 | $139.7M | +9.1% |
| Q3 2025 | $122.5M | +7% |
| Q2 2025 | $105.6M | +7.5% |
| Q1 2025 | $114.1M | +1% |
| Q4 2024 | $128.1M | +1.7% |
RCKY's revenue has grown year over year for eight quarters in a row: $139M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +3.5 points |
| Q2 2026 | 17% | +9.9 points |
| Q1 2026 | 2.9% | -4.7 points |
| Q4 2025 | 6.9% | +0.2 points |
| Q3 2025 | 9.6% | +0.8 points |
| Q2 2025 | 6.8% | +2.2 points |
| Q1 2025 | 7.6% | +0.6 points |
| Q4 2024 | 6.6% | -5.1 points |
RCKY has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
RCKY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3M | +$11.4M |
| Q2 2026 | $4.1M | +$6.5M |
| Q1 2026 | $744K | +41% |
| Q4 2025 | $16.7M | -27% |
| Q3 2025 | -$5.2M | -249% |
| Q2 2025 | -$2.4M | -151% |
| Q1 2025 | $529K | -97% |
| Q4 2024 | $22.9M | -45% |
RCKY has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
RCKY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +21K shares |
| 1 year | +1% | +76K shares |
| 3 years | +3.3% | +244K shares |
| 5 years | +3.4% | +249K shares |
| Available history | +2.4% | +180K shares |
RCKY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $201,000 |
| Q4 2021 | — |
RCKY spent $2M buying back its own shares over the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RCKY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.0x | Elevated |
RCKY's net debt is about 1.9 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RCKY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 70.6 | Neutral |
RCKY's weekly RSI is 69 (neutral) and its Stochastic is 71 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
RCKY PE vs Consumer Cyclical Sector
| Metric | RCKY | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 37% below |
| PE % | 28 | 47 | 19 pts below |
RCKY is trading at 11x earnings, a 37% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
RCKY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 8.4% above |
| 20 week MA | $45.7 | 13% above |
| 50 week MA | $40.2 | 29% above |
| 100 week MA | $32.0 | 62% above |
| 200 week MA | $29.0 | 79% above |
RCKY has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
RCKY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $28.7 | 0% |
| 2021 | $28.7 | $38.6 | +35% |
| 2022 | $38.6 | $24.0 | -38% |
| 2023 | $24.0 | $30.2 | +26% |
| 2024 | $30.2 | $22.5 | -25% |
| 2025 | $22.5 | $30.0 | +33% |
| 2026 YTD | $30.0 | $51.7 | +72% |
RCKY has the edge over LCID on returns for 2026, with the stronger performance.